alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with anandamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morisset, V; Urban, L | 1 |
| Kokona, D; Thermos, K | 1 |
2 other study(ies) available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and anandamide
| Article | Year |
|---|---|
Cannabinoid-induced presynaptic inhibition of glutamatergic EPSCs in substantia gelatinosa neurons of the rat spinal cord.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Analgesics; Animals; Arachidonic Acids; Benzoxazines; Calcium Channel Blockers; Cannabinoids; Capsaicin; Endocannabinoids; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; Glutamic Acid; Male; Morpholines; Naphthalenes; Nerve Fibers; Neural Inhibition; Neurons; Patch-Clamp Techniques; Polyunsaturated Alkamides; Presynaptic Terminals; Rats; Rats, Wistar; Substantia Gelatinosa | 2001 |
Synthetic and endogenous cannabinoids protect retinal neurons from AMPA excitotoxicity in vivo, via activation of CB1 receptors: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amacrine Cells; Animals; Apoptosis; Arachidonic Acids; Cannabinoid Receptor Agonists; Choline O-Acetyltransferase; Dose-Response Relationship, Drug; Dronabinol; Endocannabinoids; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Fluorescent Antibody Technique, Indirect; In Situ Nick-End Labeling; Intravitreal Injections; Male; MAP Kinase Signaling System; Neuroprotective Agents; Nitric Oxide Synthase Type I; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Polyunsaturated Alkamides; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1 | 2015 |